Abstract: Disclosed is an electrolyte for a rechargeable lithium battery including boron containing compounds and a rechargeable lithium battery including the same.

Abstract: The present invention relates to electrochemical storage devices containing a non-aqueous lithium based electrolyte with high ionic conductivity, low impedance, and high thermal stability. More particularly, this invention relates to the design, synthesis and application of novel fluorinated arylboron oxalate based compounds which act as anion receptors and/or additives for non-aqueous batteries. When used as an anion receptor for non-aqueous battery electrolytes, the fluorinated arylboron oxalate enhances conductivity, lithium ion transference number and Solid Electrolyte Interface (SEI) formation capability during the formation cycling.

Abstract: An ionic liquid of the formula K+A?, wherein K and A are as defined herein, can be used in such things as electrochemical cells, supercapacitors, hydraulic liquids, solvents, organic syntheses.

Abstract: The present invention relates to compounds that have a novel use as a carbon monoxide source and optionally as a reducing agent in the preparation of transition metal carbonyl complexes. The compounds are in general compounds of formula (I) wherein X1, X2 and X3 are the same or different and either a Lewis base or hydride and Y is a sigma donating group. The invention furthermore relates to a method for the preparation of borane carbonate and to the use of H3BCO as a reducing agent.

Abstract: Organic borates having the formula: The borates are highly soluble in solvent of low dielectric constant. Also disclosed are nonaqueous electrolytes made from these organic borates; lithium secondary batteries with improved high-temperature storage characteristics; and electric appliances that comprises the battery and are free of protection circuits.

Abstract: Boron heterocycle steroid mimics are provided that are useful as pharmaceutical agents, particularly in the treatment of estrogen-dependent disorders such as estrogen-dependent cancers. The compounds are also useful in diagnostic techniques such as magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS), in boron neutron capture therapy, and in fluorescence emission-based modalities. Pharmaceutical formulations and methods of using the novel compounds are provided as well.

Abstract: Boron tris-(dialkyl-dithiocarbamate) of the general formula ##STR1## wherein R and R' represent the same or different branched-or straight-chain saturated or unsaturated alkyl radicals having from 1 to 16 carbon atoms and a process for preparing the same, comprising reacting 3 moles of an alkali dialkyl-dithiocarbamate of the general formula ##STR2## wherein R and R' are as defined in claim 1 and Me.sup.+ represents Na.sup.+, K.sup.+ or NH.sub.4.sup.+ with one mole boron tribromide, boron trichloride or boron trifluoride in an inert medium, separating the so-formed alkali metal or ammonium halide and isolating the boron tris-(dialkyl-dithiocarbamate). The new boron dithiocarbamates are suitable as additives for hydraulic oils or permanent gear lubricant oils.

Abstract: Boron tris-(dialkyl-dithiocarbamate) of the general formula ##STR1## wherein R and R' represent the same or different branched- or straight-chain saturated or unsaturated alkyl radicals having from 1 to 16 carbon atoms and a process for preparing the same, comprising reacting 3 moles of an alkali dialkyl-dithiocarbamate of the general formula ##STR2## wherein R and R' are as defined in claim 1 and Me.sup.+ represents Na.sup.+, K.sup.+ or NH.sub.4.sup.+ with one mole boron tribromide, boron trichloride or boron trifluoride in an inert medium, separating the so-formed alkali metal or ammonium halide and isolating the boron dithiocarbamates are suitable as additives for hydraulic oils or permanent gear lubricant oils.